Full event guide

Brochure EB2

Here's a sneak peek of the takeaways from attending this meeting:

  • Explore the role of immunotherapy for the treatment of prostate cancer
  • Discover how to Bring theranostics to prostate cancer 
  • Evaluate how to Optimize strategies for overcoming the immunosuppressive prostate tumor microenvironment
  • Assess the opportunities and challenges for T-cell directed therapies in prostate cancer
  • Examine next-generation small molecule inhibitors, degraders of androgen receptor (AR) and AR-splice variants

    Sounds interesting? Download our official agenda to see the session details and our speaker faculty with the likes of  AmgenBristol-Myers Squibb, Novartis and Noxopharm.